07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
The Department of Homeland Security (DHS) recently announced a pilot project to collect DNA samples ...
Read More >
Driving safely is impossible if you’re impaired. It’s why driving while impaired by any legal or p...
Read More >
On July 3, California made history by enacting the Creating a Respectful and Open Workplace for Natu...
Read More >
In 2014, the Obama-era National Labor Relations Board made over two dozen changes to the union elect...
Read More >
One of the biggest changes in the 2020 FCPA Resource Guide is the addition of a new Hallmark, entitl...
Read More >
COVID-19’s impact in New York has been particularly region-specific. To address the disparity, Gove...
Read More >